 Global Biological Safety and Biocompatibility Testing Market Growth 2026-2032
The global Biological Safety and Biocompatibility Testing market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. ... もっと見る
図表リストList of TablesTable 1. Biological Safety and Biocompatibility Testing Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions) Table 2. Biological Safety and Biocompatibility Testing Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions) Table 3. Major Players of Endotoxin Test Table 4. Major Players of Sterility Test Table 5. Major Players of Mycoplasma Test Table 6. Major Players of Bioburden Test Table 7. Major Players of Residual Host-cell Proteins & DNA Detection Tests Table 8. Major Players of Virus safety Test Table 9. Major Players of Other Table 10. Global Biological Safety and Biocompatibility Testing Sales by Type (2021-2026) & (K Units) Table 11. Global Biological Safety and Biocompatibility Testing Sales Market Share by Type (2021-2026) Table 12. Global Biological Safety and Biocompatibility Testing Revenue by Type (2021-2026) & ($ million) Table 13. Global Biological Safety and Biocompatibility Testing Revenue Market Share by Type (2021-2026) Table 14. Global Biological Safety and Biocompatibility Testing Sale Price by Type (2021-2026) & (US$/Unit) Table 15. Global Biological Safety and Biocompatibility Testing Sale by Application (2021-2026) & (K Units) Table 16. Global Biological Safety and Biocompatibility Testing Sale Market Share by Application (2021-2026) Table 17. Global Biological Safety and Biocompatibility Testing Revenue by Application (2021-2026) & ($ million) Table 18. Global Biological Safety and Biocompatibility Testing Revenue Market Share by Application (2021-2026) Table 19. Global Biological Safety and Biocompatibility Testing Sale Price by Application (2021-2026) & (US$/Unit) Table 20. Global Biological Safety and Biocompatibility Testing Sales by Company (2021-2026) & (K Units) Table 21. Global Biological Safety and Biocompatibility Testing Sales Market Share by Company (2021-2026) Table 22. Global Biological Safety and Biocompatibility Testing Revenue by Company (2021-2026) & ($ millions) Table 23. Global Biological Safety and Biocompatibility Testing Revenue Market Share by Company (2021-2026) Table 24. Global Biological Safety and Biocompatibility Testing Sale Price by Company (2021-2026) & (US$/Unit) Table 25. Key Manufacturers Biological Safety and Biocompatibility Testing Producing Area Distribution and Sales Area Table 26. Players Biological Safety and Biocompatibility Testing Products Offered Table 27. Biological Safety and Biocompatibility Testing Concentration Ratio (CR3, CR5 and CR10) & (2024-2026) Table 28. New Products and Potential Entrants Table 29. Market M&A Activity & Strategy Table 30. Global Biological Safety and Biocompatibility Testing Sales by Geographic Region (2021-2026) & (K Units) Table 31. Global Biological Safety and Biocompatibility Testing Sales Market Share Geographic Region (2021-2026) Table 32. Global Biological Safety and Biocompatibility Testing Revenue by Geographic Region (2021-2026) & ($ millions) Table 33. Global Biological Safety and Biocompatibility Testing Revenue Market Share by Geographic Region (2021-2026) Table 34. Global Biological Safety and Biocompatibility Testing Sales by Country/Region (2021-2026) & (K Units) Table 35. Global Biological Safety and Biocompatibility Testing Sales Market Share by Country/Region (2021-2026) Table 36. Global Biological Safety and Biocompatibility Testing Revenue by Country/Region (2021-2026) & ($ millions) Table 37. Global Biological Safety and Biocompatibility Testing Revenue Market Share by Country/Region (2021-2026) Table 38. Americas Biological Safety and Biocompatibility Testing Sales by Country (2021-2026) & (K Units) Table 39. Americas Biological Safety and Biocompatibility Testing Sales Market Share by Country (2021-2026) Table 40. Americas Biological Safety and Biocompatibility Testing Revenue by Country (2021-2026) & ($ millions) Table 41. Americas Biological Safety and Biocompatibility Testing Sales by Type (2021-2026) & (K Units) Table 42. Americas Biological Safety and Biocompatibility Testing Sales by Application (2021-2026) & (K Units) Table 43. APAC Biological Safety and Biocompatibility Testing Sales by Region (2021-2026) & (K Units) Table 44. APAC Biological Safety and Biocompatibility Testing Sales Market Share by Region (2021-2026) Table 45. APAC Biological Safety and Biocompatibility Testing Revenue by Region (2021-2026) & ($ millions) Table 46. APAC Biological Safety and Biocompatibility Testing Sales by Type (2021-2026) & (K Units) Table 47. APAC Biological Safety and Biocompatibility Testing Sales by Application (2021-2026) & (K Units) Table 48. Europe Biological Safety and Biocompatibility Testing Sales by Country (2021-2026) & (K Units) Table 49. Europe Biological Safety and Biocompatibility Testing Revenue by Country (2021-2026) & ($ millions) Table 50. Europe Biological Safety and Biocompatibility Testing Sales by Type (2021-2026) & (K Units) Table 51. Europe Biological Safety and Biocompatibility Testing Sales by Application (2021-2026) & (K Units) Table 52. Middle East & Africa Biological Safety and Biocompatibility Testing Sales by Country (2021-2026) & (K Units) Table 53. Middle East & Africa Biological Safety and Biocompatibility Testing Revenue Market Share by Country (2021-2026) Table 54. Middle East & Africa Biological Safety and Biocompatibility Testing Sales by Type (2021-2026) & (K Units) Table 55. Middle East & Africa Biological Safety and Biocompatibility Testing Sales by Application (2021-2026) & (K Units) Table 56. Key Market Drivers & Growth Opportunities of Biological Safety and Biocompatibility Testing Table 57. Key Market Challenges & Risks of Biological Safety and Biocompatibility Testing Table 58. Key Industry Trends of Biological Safety and Biocompatibility Testing Table 59. Biological Safety and Biocompatibility Testing Raw Material Table 60. Key Suppliers of Raw Materials Table 61. Biological Safety and Biocompatibility Testing Distributors List Table 62. Biological Safety and Biocompatibility Testing Customer List Table 63. Global Biological Safety and Biocompatibility Testing Sales Forecast by Region (2027-2032) & (K Units) Table 64. Global Biological Safety and Biocompatibility Testing Revenue Forecast by Region (2027-2032) & ($ millions) Table 65. Americas Biological Safety and Biocompatibility Testing Sales Forecast by Country (2027-2032) & (K Units) Table 66. Americas Biological Safety and Biocompatibility Testing Annual Revenue Forecast by Country (2027-2032) & ($ millions) Table 67. APAC Biological Safety and Biocompatibility Testing Sales Forecast by Region (2027-2032) & (K Units) Table 68. APAC Biological Safety and Biocompatibility Testing Annual Revenue Forecast by Region (2027-2032) & ($ millions) Table 69. Europe Biological Safety and Biocompatibility Testing Sales Forecast by Country (2027-2032) & (K Units) Table 70. Europe Biological Safety and Biocompatibility Testing Revenue Forecast by Country (2027-2032) & ($ millions) Table 71. Middle East & Africa Biological Safety and Biocompatibility Testing Sales Forecast by Country (2027-2032) & (K Units) Table 72. Middle East & Africa Biological Safety and Biocompatibility Testing Revenue Forecast by Country (2027-2032) & ($ millions) Table 73. Global Biological Safety and Biocompatibility Testing Sales Forecast by Type (2027-2032) & (K Units) Table 74. Global Biological Safety and Biocompatibility Testing Revenue Forecast by Type (2027-2032) & ($ millions) Table 75. Global Biological Safety and Biocompatibility Testing Sales Forecast by Application (2027-2032) & (K Units) Table 76. Global Biological Safety and Biocompatibility Testing Revenue Forecast by Application (2027-2032) & ($ millions) Table 77. Charles River Laboratories Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 78. Charles River Laboratories Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 79. Charles River Laboratories Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Charles River Laboratories Main Business Table 81. Charles River Laboratories Latest Developments Table 82. Lonza Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 83. Lonza Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 84. Lonza Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Lonza Main Business Table 86. Lonza Latest Developments Table 87. Thermo Fisher Scientific Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 88. Thermo Fisher Scientific Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 89. Thermo Fisher Scientific Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Thermo Fisher Scientific Main Business Table 91. Thermo Fisher Scientific Latest Developments Table 92. Merck KGaA Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 93. Merck KGaA Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 94. Merck KGaA Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Merck KGaA Main Business Table 96. Merck KGaA Latest Developments Table 97. F. Hoffmann-La Roche Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 98. F. Hoffmann-La Roche Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 99. F. Hoffmann-La Roche Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. F. Hoffmann-La Roche Main Business Table 101. F. Hoffmann-La Roche Latest Developments Table 102. Agilent Technologies Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 103. Agilent Technologies Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 104. Agilent Technologies Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Agilent Technologies Main Business Table 106. Agilent Technologies Latest Developments Table 107. Labcorp Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 108. Labcorp Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 109. Labcorp Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Labcorp Main Business Table 111. Labcorp Latest Developments Table 112. SGS SA Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 113. SGS SA Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 114. SGS SA Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. SGS SA Main Business Table 116. SGS SA Latest Developments Table 117. WuXi AppTec Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 118. WuXi AppTec Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 119. WuXi AppTec Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. WuXi AppTec Main Business Table 121. WuXi AppTec Latest Developments Table 122. Sartorius AG Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 123. Sartorius AG Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 124. Sartorius AG Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Sartorius AG Main Business Table 126. Sartorius AG Latest Developments Table 127. Associates of Cape Cod Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 128. Associates of Cape Cod Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 129. Associates of Cape Cod Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Associates of Cape Cod Main Business Table 131. Associates of Cape Cod Latest Developments Table 132. bioMérieux SA Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 133. bioMérieux SA Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 134. bioMérieux SA Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. bioMérieux SA Main Business Table 136. bioMérieux SA Latest Developments Table 137. Eurofins Scientific Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 138. Eurofins Scientific Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 139. Eurofins Scientific Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Eurofins Scientific Main Business Table 141. Eurofins Scientific Latest Developments Table 142. FUJIFILM Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 143. FUJIFILM Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 144. FUJIFILM Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. FUJIFILM Main Business Table 146. FUJIFILM Latest Developments Table 147. Almac Group Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 148. Almac Group Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 149. Almac Group Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Almac Group Main Business Table 151. Almac Group Latest Developments Table 152. Bio-Rad Laboratories Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 153. Bio-Rad Laboratories Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 154. Bio-Rad Laboratories Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Bio-Rad Laboratories Main Business Table 156. Bio-Rad Laboratories Latest Developments Table 157. QIAGEN Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 158. QIAGEN Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 159. QIAGEN Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. QIAGEN Main Business Table 161. QIAGEN Latest Developments Table 162. Pacific BioLabs Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 163. Pacific BioLabs Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 164. Pacific BioLabs Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 165. Pacific BioLabs Main Business Table 166. Pacific BioLabs Latest Developments Table 167. InvivoGen Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 168. InvivoGen Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 169. InvivoGen Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 170. InvivoGen Main Business Table 171. InvivoGen Latest Developments Table 172. Microcoat Biotechnologie Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 173. Microcoat Biotechnologie Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 174. Microcoat Biotechnologie Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 175. Microcoat Biotechnologie Main Business Table 176. Microcoat Biotechnologie Latest Developments Table 177. PromoCell GmbH Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 178. PromoCell GmbH Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 179. PromoCell GmbH Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 180. PromoCell GmbH Main Business Table 181. PromoCell GmbH Latest Developments Table 182. Samsung Biologics Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 183. Samsung Biologics Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 184. Samsung Biologics Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 185. Samsung Biologics Main Business Table 186. Samsung Biologics Latest Developments Table 187. GenScript Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 188. GenScript Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 189. GenScript Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 190. GenScript Main Business Table 191. GenScript Latest Developments Table 192. Maravai Lifesciences Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 193. Maravai Lifesciences Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 194. Maravai Lifesciences Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 195. Maravai Lifesciences Main Business Table 196. Maravai Lifesciences Latest Developments Table 197. Accugen Laboratories Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 198. Accugen Laboratories Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 199. Accugen Laboratories Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 200. Accugen Laboratories Main Business Table 201. Accugen Laboratories Latest Developments Table 202. Nelson Laboratories Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 203. Nelson Laboratories Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 204. Nelson Laboratories Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 205. Nelson Laboratories Main Business Table 206. Nelson Laboratories Latest Developments List of Figures Figure 1. Picture of Biological Safety and Biocompatibility Testing Figure 2. Biological Safety and Biocompatibility Testing Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Biological Safety and Biocompatibility Testing Sales Growth Rate 2021-2032 (K Units) Figure 7. Global Biological Safety and Biocompatibility Testing Revenue Growth Rate 2021-2032 ($ millions) Figure 8. Biological Safety and Biocompatibility Testing Sales by Geographic Region (2021, 2025 & 2032) & ($ millions) Figure 9. Biological Safety and Biocompatibility Testing Sales Market Share by Country/Region (2025) Figure 10. Biological Safety and Biocompatibility Testing Sales Market Share by Country/Region (2021, 2025 & 2032) Figure 11. Product Picture of Endotoxin Test Figure 12. Product Picture of Sterility Test Figure 13. Product Picture of Mycoplasma Test Figure 14. Product Picture of Bioburden Test Figure 15. Product Picture of Residual Host-cell Proteins & DNA Detection Tests Figure 16. Product Picture of Virus safety Test Figure 17. Product Picture of Other Figure 18. Global Biological Safety and Biocompatibility Testing Sales Market Share by Type in 2026 Figure 19. Global Biological Safety and Biocompatibility Testing Revenue Market Share by Type (2021-2026) Figure 20. Biological Safety and Biocompatibility Testing Consumed in Vaccine Figure 21. Global Biological Safety and Biocompatibility Testing Market: Vaccine (2021-2026) & (K Units) Figure 22. Biological Safety and Biocompatibility Testing Consumed in Monoclonal Antibodies Figure 23. Global Biological Safety and Biocompatibility Testing Market: Monoclonal Antibodies (2021-2026) & (K Units) Figure 24. Biological Safety and Biocompatibility Testing Consumed in Cellular & Gene Therapy Products Figure 25. Global Biological Safety and Biocompatibility Testing Market: Cellular & Gene Therapy Products (2021-2026) & (K Units) Figure 26. Biological Safety and Biocompatibility Testing Consumed in Blood and Blood Products Figure 27. Global Biological Safety and Biocompatibility Testing Market: Blood and Blood Products (2021-2026) & (K Units) Figure 28. Biological Safety and Biocompatibility Testing Consumed in Other Figure 29. Global Biological Safety and Biocompatibility Testing Market: Other (2021-2026) & (K Units) Figure 30. Global Biological Safety and Biocompatibility Testing Sale Market Share by Application (2025) Figure 31. Global Biological Safety and Biocompatibility Testing Revenue Market Share by Application in 2026 Figure 32. Biological Safety and Biocompatibility Testing Sales by Company in 2026 (K Units) Figure 33. Global Biological Safety and Biocompatibility Testing Sales Market Share by Company in 2026 Figure 34. Biological Safety and Biocompatibility Testing Revenue by Company in 2026 ($ millions) Figure 35. Global Biological Safety and Biocompatibility Testing Revenue Market Share by Company in 2026 Figure 36. Global Biological Safety and Biocompatibility Testing Sales Market Share by Geographic Region (2021-2026) Figure 37. Global Biological Safety and Biocompatibility Testing Revenue Market Share by Geographic Region in 2026 Figure 38. Americas Biological Safety and Biocompatibility Testing Sales 2021-2026 (K Units) Figure 39. Americas Biological Safety and Biocompatibility Testing Revenue 2021-2026 ($ millions) Figure 40. APAC Biological Safety and Biocompatibility Testing Sales 2021-2026 (K Units) Figure 41. APAC Biological Safety and Biocompatibility Testing Revenue 2021-2026 ($ millions) Figure 42. Europe Biological Safety and Biocompatibility Testing Sales 2021-2026 (K Units) Figure 43. Europe Biological Safety and Biocompatibility Testing Revenue 2021-2026 ($ millions) Figure 44. Middle East & Africa Biological Safety and Biocompatibility Testing Sales 2021-2026 (K Units) Figure 45. Middle East & Africa Biological Safety and Biocompatibility Testing Revenue 2021-2026 ($ millions) Figure 46. Americas Biological Safety and Biocompatibility Testing Sales Market Share by Country in 2026 Figure 47. Americas Biological Safety and Biocompatibility Testing Revenue Market Share by Country (2021-2026) Figure 48. Americas Biological Safety and Biocompatibility Testing Sales Market Share by Type (2021-2026) Figure 49. Americas Biological Safety and Biocompatibility Testing Sales Market Share by Application (2021-2026) Figure 50. United States Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 51. Canada Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 52. Mexico Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 53. Brazil Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 54. APAC Biological Safety and Biocompatibility Testing Sales Market Share by Region in 2026 Figure 55. APAC Biological Safety and Biocompatibility Testing Revenue Market Share by Region (2021-2026) Figure 56. APAC Biological Safety and Biocompatibility Testing Sales Market Share by Type (2021-2026) Figure 57. APAC Biological Safety and Biocompatibility Testing Sales Market Share by Application (2021-2026) Figure 58. China Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 59. Japan Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 60. South Korea Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 61. Southeast Asia Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 62. India Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 63. Australia Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 64. China Taiwan Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 65. Europe Biological Safety and Biocompatibility Testing Sales Market Share by Country in 2026 Figure 66. Europe Biological Safety and Biocompatibility Testing Revenue Market Share by Country (2021-2026) Figure 67. Europe Biological Safety and Biocompatibility Testing Sales Market Share by Type (2021-2026) Figure 68. Europe Biological Safety and Biocompatibility Testing Sales Market Share by Application (2021-2026) Figure 69. Germany Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 70. France Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 71. UK Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 72. Italy Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 73. Russia Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 74. Middle East & Africa Biological Safety and Biocompatibility Testing Sales Market Share by Country (2021-2026) Figure 75. Middle East & Africa Biological Safety and Biocompatibility Testing Sales Market Share by Type (2021-2026) Figure 76. Middle East & Africa Biological Safety and Biocompatibility Testing Sales Market Share by Application (2021-2026) Figure 77. Egypt Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 78. South Africa Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 79. Israel Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 80. Turkey Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 81. GCC Countries Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 82. Manufacturing Cost Structure Analysis of Biological Safety and Biocompatibility Testing in 2026 Figure 83. Manufacturing Process Analysis of Biological Safety and Biocompatibility Testing Figure 84. Industry Chain Structure of Biological Safety and Biocompatibility Testing Figure 85. Channels of Distribution Figure 86. Global Biological Safety and Biocompatibility Testing Sales Market Forecast by Region (2027-2032) Figure 87. Global Biological Safety and Biocompatibility Testing Revenue Market Share Forecast by Region (2027-2032) Figure 88. Global Biological Safety and Biocompatibility Testing Sales Market Share Forecast by Type (2027-2032) Figure 89. Global Biological Safety and Biocompatibility Testing Revenue Market Share Forecast by Type (2027-2032) Figure 90. Global Biological Safety and Biocompatibility Testing Sales Market Share Forecast by Application (2027-2032) Figure 91. Global Biological Safety and Biocompatibility Testing Revenue Market Share Forecast by Application (2027-2032)
SummaryThe global Biological Safety and Biocompatibility Testing market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.Safety testing includes a set of assays used to test preclinical and clinical vector product lots prior to use in animals or humans. United States market for Biological Safety and Biocompatibility Testing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032. China market for Biological Safety and Biocompatibility Testing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032. Europe market for Biological Safety and Biocompatibility Testing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032. Global key Biological Safety and Biocompatibility Testing players cover Charles River Laboratories, Lonza, Thermo Fisher Scientific, Merck KGaA, F. Hoffmann-La Roche, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025. LP Information, Inc. (LPI) ' newest research report, the “Biological Safety and Biocompatibility Testing Industry Forecast” looks at past sales and reviews total world Biological Safety and Biocompatibility Testing sales in 2025, providing a comprehensive analysis by region and market sector of projected Biological Safety and Biocompatibility Testing sales for 2026 through 2032. With Biological Safety and Biocompatibility Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biological Safety and Biocompatibility Testing industry. This Insight Report provides a comprehensive analysis of the global Biological Safety and Biocompatibility Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biological Safety and Biocompatibility Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biological Safety and Biocompatibility Testing market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biological Safety and Biocompatibility Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biological Safety and Biocompatibility Testing. This report presents a comprehensive overview, market shares, and growth opportunities of Biological Safety and Biocompatibility Testing market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: Endotoxin Test Sterility Test Mycoplasma Test Bioburden Test Residual Host-cell Proteins & DNA Detection Tests Virus safety Test Other Segmentation by Application: Vaccine Monoclonal Antibodies Cellular & Gene Therapy Products Blood and Blood Products Other This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration. Charles River Laboratories Lonza Thermo Fisher Scientific Merck KGaA F. Hoffmann-La Roche Agilent Technologies Labcorp SGS SA WuXi AppTec Sartorius AG Associates of Cape Cod bioMérieux SA Eurofins Scientific FUJIFILM Almac Group Bio-Rad Laboratories QIAGEN Pacific BioLabs InvivoGen Microcoat Biotechnologie PromoCell GmbH Samsung Biologics GenScript Maravai Lifesciences Accugen Laboratories Nelson Laboratories Key Questions Addressed in this Report What is the 10-year outlook for the global Biological Safety and Biocompatibility Testing market? What factors are driving Biological Safety and Biocompatibility Testing market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Biological Safety and Biocompatibility Testing market opportunities vary by end market size? How does Biological Safety and Biocompatibility Testing break out by Type, by Application? Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Biological Safety and Biocompatibility Testing Annual Sales 2021-2032 2.1.2 World Current & Future Analysis for Biological Safety and Biocompatibility Testing by Geographic Region, 2021, 2025 & 2032 2.1.3 World Current & Future Analysis for Biological Safety and Biocompatibility Testing by Country/Region, 2021, 2025 & 2032 2.2 Biological Safety and Biocompatibility Testing Segment by Type 2.2.1 Endotoxin Test 2.2.2 Sterility Test 2.2.3 Mycoplasma Test 2.2.4 Bioburden Test 2.2.5 Residual Host-cell Proteins & DNA Detection Tests 2.2.6 Virus safety Test 2.2.7 Other 2.2.8 Biological Safety and Biocompatibility Testing Sales by Type 2.2.8.1 Global Biological Safety and Biocompatibility Testing Sales Market Share by Type (2021-2026) 2.2.8.2 Global Biological Safety and Biocompatibility Testing Revenue and Market Share by Type (2021-2026) 2.2.8.3 Global Biological Safety and Biocompatibility Testing Sale Price by Type (2021-2026) 2.3 Biological Safety and Biocompatibility Testing Segment by Application 2.3.1 Vaccine 2.3.2 Monoclonal Antibodies 2.3.3 Cellular & Gene Therapy Products 2.3.4 Blood and Blood Products 2.3.5 Other 2.3.6 Biological Safety and Biocompatibility Testing Sales by Application 2.3.6.1 Global Biological Safety and Biocompatibility Testing Sale Market Share by Application (2021-2026) 2.3.6.2 Global Biological Safety and Biocompatibility Testing Revenue and Market Share by Application (2021-2026) 2.3.6.3 Global Biological Safety and Biocompatibility Testing Sale Price by Application (2021-2026) 3 Global by Company 3.1 Global Biological Safety and Biocompatibility Testing Breakdown Data by Company 3.1.1 Global Biological Safety and Biocompatibility Testing Annual Sales by Company (2021-2026) 3.1.2 Global Biological Safety and Biocompatibility Testing Sales Market Share by Company (2021-2026) 3.2 Global Biological Safety and Biocompatibility Testing Annual Revenue by Company (2021-2026) 3.2.1 Global Biological Safety and Biocompatibility Testing Revenue by Company (2021-2026) 3.2.2 Global Biological Safety and Biocompatibility Testing Revenue Market Share by Company (2021-2026) 3.3 Global Biological Safety and Biocompatibility Testing Sale Price by Company 3.4 Key Manufacturers Biological Safety and Biocompatibility Testing Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Biological Safety and Biocompatibility Testing Product Location Distribution 3.4.2 Players Biological Safety and Biocompatibility Testing Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026) 3.6 New Products and Potential Entrants 3.7 Market M&A Activity & Strategy 4 World Historic Review for Biological Safety and Biocompatibility Testing by Geographic Region 4.1 World Historic Biological Safety and Biocompatibility Testing Market Size by Geographic Region (2021-2026) 4.1.1 Global Biological Safety and Biocompatibility Testing Annual Sales by Geographic Region (2021-2026) 4.1.2 Global Biological Safety and Biocompatibility Testing Annual Revenue by Geographic Region (2021-2026) 4.2 World Historic Biological Safety and Biocompatibility Testing Market Size by Country/Region (2021-2026) 4.2.1 Global Biological Safety and Biocompatibility Testing Annual Sales by Country/Region (2021-2026) 4.2.2 Global Biological Safety and Biocompatibility Testing Annual Revenue by Country/Region (2021-2026) 4.3 Americas Biological Safety and Biocompatibility Testing Sales Growth 4.4 APAC Biological Safety and Biocompatibility Testing Sales Growth 4.5 Europe Biological Safety and Biocompatibility Testing Sales Growth 4.6 Middle East & Africa Biological Safety and Biocompatibility Testing Sales Growth 5 Americas 5.1 Americas Biological Safety and Biocompatibility Testing Sales by Country 5.1.1 Americas Biological Safety and Biocompatibility Testing Sales by Country (2021-2026) 5.1.2 Americas Biological Safety and Biocompatibility Testing Revenue by Country (2021-2026) 5.2 Americas Biological Safety and Biocompatibility Testing Sales by Type (2021-2026) 5.3 Americas Biological Safety and Biocompatibility Testing Sales by Application (2021-2026) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Biological Safety and Biocompatibility Testing Sales by Region 6.1.1 APAC Biological Safety and Biocompatibility Testing Sales by Region (2021-2026) 6.1.2 APAC Biological Safety and Biocompatibility Testing Revenue by Region (2021-2026) 6.2 APAC Biological Safety and Biocompatibility Testing Sales by Type (2021-2026) 6.3 APAC Biological Safety and Biocompatibility Testing Sales by Application (2021-2026) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Biological Safety and Biocompatibility Testing by Country 7.1.1 Europe Biological Safety and Biocompatibility Testing Sales by Country (2021-2026) 7.1.2 Europe Biological Safety and Biocompatibility Testing Revenue by Country (2021-2026) 7.2 Europe Biological Safety and Biocompatibility Testing Sales by Type (2021-2026) 7.3 Europe Biological Safety and Biocompatibility Testing Sales by Application (2021-2026) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Biological Safety and Biocompatibility Testing by Country 8.1.1 Middle East & Africa Biological Safety and Biocompatibility Testing Sales by Country (2021-2026) 8.1.2 Middle East & Africa Biological Safety and Biocompatibility Testing Revenue by Country (2021-2026) 8.2 Middle East & Africa Biological Safety and Biocompatibility Testing Sales by Type (2021-2026) 8.3 Middle East & Africa Biological Safety and Biocompatibility Testing Sales by Application (2021-2026) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Biological Safety and Biocompatibility Testing 10.3 Manufacturing Process Analysis of Biological Safety and Biocompatibility Testing 10.4 Industry Chain Structure of Biological Safety and Biocompatibility Testing 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Biological Safety and Biocompatibility Testing Distributors 11.3 Biological Safety and Biocompatibility Testing Customer 12 World Forecast Review for Biological Safety and Biocompatibility Testing by Geographic Region 12.1 Global Biological Safety and Biocompatibility Testing Market Size Forecast by Region 12.1.1 Global Biological Safety and Biocompatibility Testing Forecast by Region (2027-2032) 12.1.2 Global Biological Safety and Biocompatibility Testing Annual Revenue Forecast by Region (2027-2032) 12.2 Americas Forecast by Country (2027-2032) 12.3 APAC Forecast by Region (2027-2032) 12.4 Europe Forecast by Country (2027-2032) 12.5 Middle East & Africa Forecast by Country (2027-2032) 12.6 Global Biological Safety and Biocompatibility Testing Forecast by Type (2027-2032) 12.7 Global Biological Safety and Biocompatibility Testing Forecast by Application (2027-2032) 13 Key Players Analysis 13.1 Charles River Laboratories 13.1.1 Charles River Laboratories Company Information 13.1.2 Charles River Laboratories Biological Safety and Biocompatibility Testing Product Portfolios and Specifications 13.1.3 Charles River Laboratories Biological Safety and Biocompatibility Testing Sales, Revenue, Price and Gross Margin (2021-2026) 13.1.4 Charles River Laboratories Main Business Overview 13.1.5 Charles River Laboratories Latest Developments 13.2 Lonza 13.2.1 Lonza Company Information 13.2.2 Lonza Biological Safety and Biocompatibility Testing Product Portfolios and Specifications 13.2.3 Lonza Biological Safety and Biocompatibility Testing Sales, Revenue, Price and Gross Margin (2021-2026) 13.2.4 Lonza Main Business Overview 13.2.5 Lonza Latest Developments 13.3 Thermo Fisher Scientific 13.3.1 Thermo Fisher Scientific Company Information 13.3.2 Thermo Fisher Scientific Biological Safety and Biocompatibility Testing Product Portfolios and Specifications 13.3.3 Thermo Fisher Scientific Biological Safety and Biocompatibility Testing Sales, Revenue, Price and Gross Margin (2021-2026) 13.3.4 Thermo Fisher Scientific Main Business Overview 13.3.5 Thermo Fisher Scientific Latest Developments 13.4 Merck KGaA 13.4.1 Merck KGaA Company Information 13.4.2 Merck KGaA Biological Safety and Biocompatibility Testing Product Portfolios and Specifications 13.4.3 Merck KGaA Biological Safety and Biocompatibility Testing Sales, Revenue, Price and Gross Margin (2021-2026) 13.4.4 Merck KGaA Main Business Overview 13.4.5 Merck KGaA Latest Developments 13.5 F. Hoffmann-La Roche 13.5.1 F. Hoffmann-La Roche Company Information 13.5.2 F. Hoffmann-La Roche Biological Safety and Biocompatibility Testing Product Portfolios and Specifications 13.5.3 F. Hoffmann-La Roche Biological Safety and Biocompatibility Testing Sales, Revenue, Price and Gross Margin (2021-2026) 13.5.4 F. Hoffmann-La Roche Main Business Overview 13.5.5 F. Hoffmann-La Roche Latest Developments 13.6 Agilent Technologies 13.6.1 Agilent Technologies Company Information 13.6.2 Agilent Technologies Biological Safety and Biocompatibility Testing Product Portfolios and Specifications 13.6.3 Agilent Technologies Biological Safety and Biocompatibility Testing Sales, Revenue, Price and Gross Margin (2021-2026) 13.6.4 Agilent Technologies Main Business Overview 13.6.5 Agilent Technologies Latest Developments 13.7 Labcorp 13.7.1 Labcorp Company Information 13.7.2 Labcorp Biological Safety and Biocompatibility Testing Product Portfolios and Specifications 13.7.3 Labcorp Biological Safety and Biocompatibility Testing Sales, Revenue, Price and Gross Margin (2021-2026) 13.7.4 Labcorp Main Business Overview 13.7.5 Labcorp Latest Developments 13.8 SGS SA 13.8.1 SGS SA Company Information 13.8.2 SGS SA Biological Safety and Biocompatibility Testing Product Portfolios and Specifications 13.8.3 SGS SA Biological Safety and Biocompatibility Testing Sales, Revenue, Price and Gross Margin (2021-2026) 13.8.4 SGS SA Main Business Overview 13.8.5 SGS SA Latest Developments 13.9 WuXi AppTec 13.9.1 WuXi AppTec Company Information 13.9.2 WuXi AppTec Biological Safety and Biocompatibility Testing Product Portfolios and Specifications 13.9.3 WuXi AppTec Biological Safety and Biocompatibility Testing Sales, Revenue, Price and Gross Margin (2021-2026) 13.9.4 WuXi AppTec Main Business Overview 13.9.5 WuXi AppTec Latest Developments 13.10 Sartorius AG 13.10.1 Sartorius AG Company Information 13.10.2 Sartorius AG Biological Safety and Biocompatibility Testing Product Portfolios and Specifications 13.10.3 Sartorius AG Biological Safety and Biocompatibility Testing Sales, Revenue, Price and Gross Margin (2021-2026) 13.10.4 Sartorius AG Main Business Overview 13.10.5 Sartorius AG Latest Developments 13.11 Associates of Cape Cod 13.11.1 Associates of Cape Cod Company Information 13.11.2 Associates of Cape Cod Biological Safety and Biocompatibility Testing Product Portfolios and Specifications 13.11.3 Associates of Cape Cod Biological Safety and Biocompatibility Testing Sales, Revenue, Price and Gross Margin (2021-2026) 13.11.4 Associates of Cape Cod Main Business Overview 13.11.5 Associates of Cape Cod Latest Developments 13.12 bioMérieux SA 13.12.1 bioMérieux SA Company Information 13.12.2 bioMérieux SA Biological Safety and Biocompatibility Testing Product Portfolios and Specifications 13.12.3 bioMérieux SA Biological Safety and Biocompatibility Testing Sales, Revenue, Price and Gross Margin (2021-2026) 13.12.4 bioMérieux SA Main Business Overview 13.12.5 bioMérieux SA Latest Developments 13.13 Eurofins Scientific 13.13.1 Eurofins Scientific Company Information 13.13.2 Eurofins Scientific Biological Safety and Biocompatibility Testing Product Portfolios and Specifications 13.13.3 Eurofins Scientific Biological Safety and Biocompatibility Testing Sales, Revenue, Price and Gross Margin (2021-2026) 13.13.4 Eurofins Scientific Main Business Overview 13.13.5 Eurofins Scientific Latest Developments 13.14 FUJIFILM 13.14.1 FUJIFILM Company Information 13.14.2 FUJIFILM Biological Safety and Biocompatibility Testing Product Portfolios and Specifications 13.14.3 FUJIFILM Biological Safety and Biocompatibility Testing Sales, Revenue, Price and Gross Margin (2021-2026) 13.14.4 FUJIFILM Main Business Overview 13.14.5 FUJIFILM Latest Developments 13.15 Almac Group 13.15.1 Almac Group Company Information 13.15.2 Almac Group Biological Safety and Biocompatibility Testing Product Portfolios and Specifications 13.15.3 Almac Group Biological Safety and Biocompatibility Testing Sales, Revenue, Price and Gross Margin (2021-2026) 13.15.4 Almac Group Main Business Overview 13.15.5 Almac Group Latest Developments 13.16 Bio-Rad Laboratories 13.16.1 Bio-Rad Laboratories Company Information 13.16.2 Bio-Rad Laboratories Biological Safety and Biocompatibility Testing Product Portfolios and Specifications 13.16.3 Bio-Rad Laboratories Biological Safety and Biocompatibility Testing Sales, Revenue, Price and Gross Margin (2021-2026) 13.16.4 Bio-Rad Laboratories Main Business Overview 13.16.5 Bio-Rad Laboratories Latest Developments 13.17 QIAGEN 13.17.1 QIAGEN Company Information 13.17.2 QIAGEN Biological Safety and Biocompatibility Testing Product Portfolios and Specifications 13.17.3 QIAGEN Biological Safety and Biocompatibility Testing Sales, Revenue, Price and Gross Margin (2021-2026) 13.17.4 QIAGEN Main Business Overview 13.17.5 QIAGEN Latest Developments 13.18 Pacific BioLabs 13.18.1 Pacific BioLabs Company Information 13.18.2 Pacific BioLabs Biological Safety and Biocompatibility Testing Product Portfolios and Specifications 13.18.3 Pacific BioLabs Biological Safety and Biocompatibility Testing Sales, Revenue, Price and Gross Margin (2021-2026) 13.18.4 Pacific BioLabs Main Business Overview 13.18.5 Pacific BioLabs Latest Developments 13.19 InvivoGen 13.19.1 InvivoGen Company Information 13.19.2 InvivoGen Biological Safety and Biocompatibility Testing Product Portfolios and Specifications 13.19.3 InvivoGen Biological Safety and Biocompatibility Testing Sales, Revenue, Price and Gross Margin (2021-2026) 13.19.4 InvivoGen Main Business Overview 13.19.5 InvivoGen Latest Developments 13.20 Microcoat Biotechnologie 13.20.1 Microcoat Biotechnologie Company Information 13.20.2 Microcoat Biotechnologie Biological Safety and Biocompatibility Testing Product Portfolios and Specifications 13.20.3 Microcoat Biotechnologie Biological Safety and Biocompatibility Testing Sales, Revenue, Price and Gross Margin (2021-2026) 13.20.4 Microcoat Biotechnologie Main Business Overview 13.20.5 Microcoat Biotechnologie Latest Developments 13.21 PromoCell GmbH 13.21.1 PromoCell GmbH Company Information 13.21.2 PromoCell GmbH Biological Safety and Biocompatibility Testing Product Portfolios and Specifications 13.21.3 PromoCell GmbH Biological Safety and Biocompatibility Testing Sales, Revenue, Price and Gross Margin (2021-2026) 13.21.4 PromoCell GmbH Main Business Overview 13.21.5 PromoCell GmbH Latest Developments 13.22 Samsung Biologics 13.22.1 Samsung Biologics Company Information 13.22.2 Samsung Biologics Biological Safety and Biocompatibility Testing Product Portfolios and Specifications 13.22.3 Samsung Biologics Biological Safety and Biocompatibility Testing Sales, Revenue, Price and Gross Margin (2021-2026) 13.22.4 Samsung Biologics Main Business Overview 13.22.5 Samsung Biologics Latest Developments 13.23 GenScript 13.23.1 GenScript Company Information 13.23.2 GenScript Biological Safety and Biocompatibility Testing Product Portfolios and Specifications 13.23.3 GenScript Biological Safety and Biocompatibility Testing Sales, Revenue, Price and Gross Margin (2021-2026) 13.23.4 GenScript Main Business Overview 13.23.5 GenScript Latest Developments 13.24 Maravai Lifesciences 13.24.1 Maravai Lifesciences Company Information 13.24.2 Maravai Lifesciences Biological Safety and Biocompatibility Testing Product Portfolios and Specifications 13.24.3 Maravai Lifesciences Biological Safety and Biocompatibility Testing Sales, Revenue, Price and Gross Margin (2021-2026) 13.24.4 Maravai Lifesciences Main Business Overview 13.24.5 Maravai Lifesciences Latest Developments 13.25 Accugen Laboratories 13.25.1 Accugen Laboratories Company Information 13.25.2 Accugen Laboratories Biological Safety and Biocompatibility Testing Product Portfolios and Specifications 13.25.3 Accugen Laboratories Biological Safety and Biocompatibility Testing Sales, Revenue, Price and Gross Margin (2021-2026) 13.25.4 Accugen Laboratories Main Business Overview 13.25.5 Accugen Laboratories Latest Developments 13.26 Nelson Laboratories 13.26.1 Nelson Laboratories Company Information 13.26.2 Nelson Laboratories Biological Safety and Biocompatibility Testing Product Portfolios and Specifications 13.26.3 Nelson Laboratories Biological Safety and Biocompatibility Testing Sales, Revenue, Price and Gross Margin (2021-2026) 13.26.4 Nelson Laboratories Main Business Overview 13.26.5 Nelson Laboratories Latest Developments 14 Research Findings and Conclusion List of Tables/GraphsList of TablesTable 1. Biological Safety and Biocompatibility Testing Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions) Table 2. Biological Safety and Biocompatibility Testing Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions) Table 3. Major Players of Endotoxin Test Table 4. Major Players of Sterility Test Table 5. Major Players of Mycoplasma Test Table 6. Major Players of Bioburden Test Table 7. Major Players of Residual Host-cell Proteins & DNA Detection Tests Table 8. Major Players of Virus safety Test Table 9. Major Players of Other Table 10. Global Biological Safety and Biocompatibility Testing Sales by Type (2021-2026) & (K Units) Table 11. Global Biological Safety and Biocompatibility Testing Sales Market Share by Type (2021-2026) Table 12. Global Biological Safety and Biocompatibility Testing Revenue by Type (2021-2026) & ($ million) Table 13. Global Biological Safety and Biocompatibility Testing Revenue Market Share by Type (2021-2026) Table 14. Global Biological Safety and Biocompatibility Testing Sale Price by Type (2021-2026) & (US$/Unit) Table 15. Global Biological Safety and Biocompatibility Testing Sale by Application (2021-2026) & (K Units) Table 16. Global Biological Safety and Biocompatibility Testing Sale Market Share by Application (2021-2026) Table 17. Global Biological Safety and Biocompatibility Testing Revenue by Application (2021-2026) & ($ million) Table 18. Global Biological Safety and Biocompatibility Testing Revenue Market Share by Application (2021-2026) Table 19. Global Biological Safety and Biocompatibility Testing Sale Price by Application (2021-2026) & (US$/Unit) Table 20. Global Biological Safety and Biocompatibility Testing Sales by Company (2021-2026) & (K Units) Table 21. Global Biological Safety and Biocompatibility Testing Sales Market Share by Company (2021-2026) Table 22. Global Biological Safety and Biocompatibility Testing Revenue by Company (2021-2026) & ($ millions) Table 23. Global Biological Safety and Biocompatibility Testing Revenue Market Share by Company (2021-2026) Table 24. Global Biological Safety and Biocompatibility Testing Sale Price by Company (2021-2026) & (US$/Unit) Table 25. Key Manufacturers Biological Safety and Biocompatibility Testing Producing Area Distribution and Sales Area Table 26. Players Biological Safety and Biocompatibility Testing Products Offered Table 27. Biological Safety and Biocompatibility Testing Concentration Ratio (CR3, CR5 and CR10) & (2024-2026) Table 28. New Products and Potential Entrants Table 29. Market M&A Activity & Strategy Table 30. Global Biological Safety and Biocompatibility Testing Sales by Geographic Region (2021-2026) & (K Units) Table 31. Global Biological Safety and Biocompatibility Testing Sales Market Share Geographic Region (2021-2026) Table 32. Global Biological Safety and Biocompatibility Testing Revenue by Geographic Region (2021-2026) & ($ millions) Table 33. Global Biological Safety and Biocompatibility Testing Revenue Market Share by Geographic Region (2021-2026) Table 34. Global Biological Safety and Biocompatibility Testing Sales by Country/Region (2021-2026) & (K Units) Table 35. Global Biological Safety and Biocompatibility Testing Sales Market Share by Country/Region (2021-2026) Table 36. Global Biological Safety and Biocompatibility Testing Revenue by Country/Region (2021-2026) & ($ millions) Table 37. Global Biological Safety and Biocompatibility Testing Revenue Market Share by Country/Region (2021-2026) Table 38. Americas Biological Safety and Biocompatibility Testing Sales by Country (2021-2026) & (K Units) Table 39. Americas Biological Safety and Biocompatibility Testing Sales Market Share by Country (2021-2026) Table 40. Americas Biological Safety and Biocompatibility Testing Revenue by Country (2021-2026) & ($ millions) Table 41. Americas Biological Safety and Biocompatibility Testing Sales by Type (2021-2026) & (K Units) Table 42. Americas Biological Safety and Biocompatibility Testing Sales by Application (2021-2026) & (K Units) Table 43. APAC Biological Safety and Biocompatibility Testing Sales by Region (2021-2026) & (K Units) Table 44. APAC Biological Safety and Biocompatibility Testing Sales Market Share by Region (2021-2026) Table 45. APAC Biological Safety and Biocompatibility Testing Revenue by Region (2021-2026) & ($ millions) Table 46. APAC Biological Safety and Biocompatibility Testing Sales by Type (2021-2026) & (K Units) Table 47. APAC Biological Safety and Biocompatibility Testing Sales by Application (2021-2026) & (K Units) Table 48. Europe Biological Safety and Biocompatibility Testing Sales by Country (2021-2026) & (K Units) Table 49. Europe Biological Safety and Biocompatibility Testing Revenue by Country (2021-2026) & ($ millions) Table 50. Europe Biological Safety and Biocompatibility Testing Sales by Type (2021-2026) & (K Units) Table 51. Europe Biological Safety and Biocompatibility Testing Sales by Application (2021-2026) & (K Units) Table 52. Middle East & Africa Biological Safety and Biocompatibility Testing Sales by Country (2021-2026) & (K Units) Table 53. Middle East & Africa Biological Safety and Biocompatibility Testing Revenue Market Share by Country (2021-2026) Table 54. Middle East & Africa Biological Safety and Biocompatibility Testing Sales by Type (2021-2026) & (K Units) Table 55. Middle East & Africa Biological Safety and Biocompatibility Testing Sales by Application (2021-2026) & (K Units) Table 56. Key Market Drivers & Growth Opportunities of Biological Safety and Biocompatibility Testing Table 57. Key Market Challenges & Risks of Biological Safety and Biocompatibility Testing Table 58. Key Industry Trends of Biological Safety and Biocompatibility Testing Table 59. Biological Safety and Biocompatibility Testing Raw Material Table 60. Key Suppliers of Raw Materials Table 61. Biological Safety and Biocompatibility Testing Distributors List Table 62. Biological Safety and Biocompatibility Testing Customer List Table 63. Global Biological Safety and Biocompatibility Testing Sales Forecast by Region (2027-2032) & (K Units) Table 64. Global Biological Safety and Biocompatibility Testing Revenue Forecast by Region (2027-2032) & ($ millions) Table 65. Americas Biological Safety and Biocompatibility Testing Sales Forecast by Country (2027-2032) & (K Units) Table 66. Americas Biological Safety and Biocompatibility Testing Annual Revenue Forecast by Country (2027-2032) & ($ millions) Table 67. APAC Biological Safety and Biocompatibility Testing Sales Forecast by Region (2027-2032) & (K Units) Table 68. APAC Biological Safety and Biocompatibility Testing Annual Revenue Forecast by Region (2027-2032) & ($ millions) Table 69. Europe Biological Safety and Biocompatibility Testing Sales Forecast by Country (2027-2032) & (K Units) Table 70. Europe Biological Safety and Biocompatibility Testing Revenue Forecast by Country (2027-2032) & ($ millions) Table 71. Middle East & Africa Biological Safety and Biocompatibility Testing Sales Forecast by Country (2027-2032) & (K Units) Table 72. Middle East & Africa Biological Safety and Biocompatibility Testing Revenue Forecast by Country (2027-2032) & ($ millions) Table 73. Global Biological Safety and Biocompatibility Testing Sales Forecast by Type (2027-2032) & (K Units) Table 74. Global Biological Safety and Biocompatibility Testing Revenue Forecast by Type (2027-2032) & ($ millions) Table 75. Global Biological Safety and Biocompatibility Testing Sales Forecast by Application (2027-2032) & (K Units) Table 76. Global Biological Safety and Biocompatibility Testing Revenue Forecast by Application (2027-2032) & ($ millions) Table 77. Charles River Laboratories Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 78. Charles River Laboratories Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 79. Charles River Laboratories Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Charles River Laboratories Main Business Table 81. Charles River Laboratories Latest Developments Table 82. Lonza Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 83. Lonza Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 84. Lonza Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Lonza Main Business Table 86. Lonza Latest Developments Table 87. Thermo Fisher Scientific Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 88. Thermo Fisher Scientific Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 89. Thermo Fisher Scientific Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Thermo Fisher Scientific Main Business Table 91. Thermo Fisher Scientific Latest Developments Table 92. Merck KGaA Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 93. Merck KGaA Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 94. Merck KGaA Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Merck KGaA Main Business Table 96. Merck KGaA Latest Developments Table 97. F. Hoffmann-La Roche Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 98. F. Hoffmann-La Roche Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 99. F. Hoffmann-La Roche Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. F. Hoffmann-La Roche Main Business Table 101. F. Hoffmann-La Roche Latest Developments Table 102. Agilent Technologies Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 103. Agilent Technologies Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 104. Agilent Technologies Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Agilent Technologies Main Business Table 106. Agilent Technologies Latest Developments Table 107. Labcorp Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 108. Labcorp Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 109. Labcorp Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Labcorp Main Business Table 111. Labcorp Latest Developments Table 112. SGS SA Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 113. SGS SA Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 114. SGS SA Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. SGS SA Main Business Table 116. SGS SA Latest Developments Table 117. WuXi AppTec Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 118. WuXi AppTec Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 119. WuXi AppTec Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. WuXi AppTec Main Business Table 121. WuXi AppTec Latest Developments Table 122. Sartorius AG Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 123. Sartorius AG Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 124. Sartorius AG Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Sartorius AG Main Business Table 126. Sartorius AG Latest Developments Table 127. Associates of Cape Cod Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 128. Associates of Cape Cod Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 129. Associates of Cape Cod Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Associates of Cape Cod Main Business Table 131. Associates of Cape Cod Latest Developments Table 132. bioMérieux SA Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 133. bioMérieux SA Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 134. bioMérieux SA Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. bioMérieux SA Main Business Table 136. bioMérieux SA Latest Developments Table 137. Eurofins Scientific Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 138. Eurofins Scientific Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 139. Eurofins Scientific Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Eurofins Scientific Main Business Table 141. Eurofins Scientific Latest Developments Table 142. FUJIFILM Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 143. FUJIFILM Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 144. FUJIFILM Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. FUJIFILM Main Business Table 146. FUJIFILM Latest Developments Table 147. Almac Group Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 148. Almac Group Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 149. Almac Group Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Almac Group Main Business Table 151. Almac Group Latest Developments Table 152. Bio-Rad Laboratories Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 153. Bio-Rad Laboratories Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 154. Bio-Rad Laboratories Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Bio-Rad Laboratories Main Business Table 156. Bio-Rad Laboratories Latest Developments Table 157. QIAGEN Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 158. QIAGEN Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 159. QIAGEN Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. QIAGEN Main Business Table 161. QIAGEN Latest Developments Table 162. Pacific BioLabs Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 163. Pacific BioLabs Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 164. Pacific BioLabs Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 165. Pacific BioLabs Main Business Table 166. Pacific BioLabs Latest Developments Table 167. InvivoGen Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 168. InvivoGen Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 169. InvivoGen Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 170. InvivoGen Main Business Table 171. InvivoGen Latest Developments Table 172. Microcoat Biotechnologie Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 173. Microcoat Biotechnologie Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 174. Microcoat Biotechnologie Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 175. Microcoat Biotechnologie Main Business Table 176. Microcoat Biotechnologie Latest Developments Table 177. PromoCell GmbH Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 178. PromoCell GmbH Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 179. PromoCell GmbH Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 180. PromoCell GmbH Main Business Table 181. PromoCell GmbH Latest Developments Table 182. Samsung Biologics Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 183. Samsung Biologics Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 184. Samsung Biologics Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 185. Samsung Biologics Main Business Table 186. Samsung Biologics Latest Developments Table 187. GenScript Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 188. GenScript Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 189. GenScript Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 190. GenScript Main Business Table 191. GenScript Latest Developments Table 192. Maravai Lifesciences Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 193. Maravai Lifesciences Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 194. Maravai Lifesciences Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 195. Maravai Lifesciences Main Business Table 196. Maravai Lifesciences Latest Developments Table 197. Accugen Laboratories Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 198. Accugen Laboratories Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 199. Accugen Laboratories Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 200. Accugen Laboratories Main Business Table 201. Accugen Laboratories Latest Developments Table 202. Nelson Laboratories Basic Information, Biological Safety and Biocompatibility Testing Manufacturing Base, Sales Area and Its Competitors Table 203. Nelson Laboratories Biological Safety and Biocompatibility Testing Product Portfolios and Specifications Table 204. Nelson Laboratories Biological Safety and Biocompatibility Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 205. Nelson Laboratories Main Business Table 206. Nelson Laboratories Latest Developments List of Figures Figure 1. Picture of Biological Safety and Biocompatibility Testing Figure 2. Biological Safety and Biocompatibility Testing Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Biological Safety and Biocompatibility Testing Sales Growth Rate 2021-2032 (K Units) Figure 7. Global Biological Safety and Biocompatibility Testing Revenue Growth Rate 2021-2032 ($ millions) Figure 8. Biological Safety and Biocompatibility Testing Sales by Geographic Region (2021, 2025 & 2032) & ($ millions) Figure 9. Biological Safety and Biocompatibility Testing Sales Market Share by Country/Region (2025) Figure 10. Biological Safety and Biocompatibility Testing Sales Market Share by Country/Region (2021, 2025 & 2032) Figure 11. Product Picture of Endotoxin Test Figure 12. Product Picture of Sterility Test Figure 13. Product Picture of Mycoplasma Test Figure 14. Product Picture of Bioburden Test Figure 15. Product Picture of Residual Host-cell Proteins & DNA Detection Tests Figure 16. Product Picture of Virus safety Test Figure 17. Product Picture of Other Figure 18. Global Biological Safety and Biocompatibility Testing Sales Market Share by Type in 2026 Figure 19. Global Biological Safety and Biocompatibility Testing Revenue Market Share by Type (2021-2026) Figure 20. Biological Safety and Biocompatibility Testing Consumed in Vaccine Figure 21. Global Biological Safety and Biocompatibility Testing Market: Vaccine (2021-2026) & (K Units) Figure 22. Biological Safety and Biocompatibility Testing Consumed in Monoclonal Antibodies Figure 23. Global Biological Safety and Biocompatibility Testing Market: Monoclonal Antibodies (2021-2026) & (K Units) Figure 24. Biological Safety and Biocompatibility Testing Consumed in Cellular & Gene Therapy Products Figure 25. Global Biological Safety and Biocompatibility Testing Market: Cellular & Gene Therapy Products (2021-2026) & (K Units) Figure 26. Biological Safety and Biocompatibility Testing Consumed in Blood and Blood Products Figure 27. Global Biological Safety and Biocompatibility Testing Market: Blood and Blood Products (2021-2026) & (K Units) Figure 28. Biological Safety and Biocompatibility Testing Consumed in Other Figure 29. Global Biological Safety and Biocompatibility Testing Market: Other (2021-2026) & (K Units) Figure 30. Global Biological Safety and Biocompatibility Testing Sale Market Share by Application (2025) Figure 31. Global Biological Safety and Biocompatibility Testing Revenue Market Share by Application in 2026 Figure 32. Biological Safety and Biocompatibility Testing Sales by Company in 2026 (K Units) Figure 33. Global Biological Safety and Biocompatibility Testing Sales Market Share by Company in 2026 Figure 34. Biological Safety and Biocompatibility Testing Revenue by Company in 2026 ($ millions) Figure 35. Global Biological Safety and Biocompatibility Testing Revenue Market Share by Company in 2026 Figure 36. Global Biological Safety and Biocompatibility Testing Sales Market Share by Geographic Region (2021-2026) Figure 37. Global Biological Safety and Biocompatibility Testing Revenue Market Share by Geographic Region in 2026 Figure 38. Americas Biological Safety and Biocompatibility Testing Sales 2021-2026 (K Units) Figure 39. Americas Biological Safety and Biocompatibility Testing Revenue 2021-2026 ($ millions) Figure 40. APAC Biological Safety and Biocompatibility Testing Sales 2021-2026 (K Units) Figure 41. APAC Biological Safety and Biocompatibility Testing Revenue 2021-2026 ($ millions) Figure 42. Europe Biological Safety and Biocompatibility Testing Sales 2021-2026 (K Units) Figure 43. Europe Biological Safety and Biocompatibility Testing Revenue 2021-2026 ($ millions) Figure 44. Middle East & Africa Biological Safety and Biocompatibility Testing Sales 2021-2026 (K Units) Figure 45. Middle East & Africa Biological Safety and Biocompatibility Testing Revenue 2021-2026 ($ millions) Figure 46. Americas Biological Safety and Biocompatibility Testing Sales Market Share by Country in 2026 Figure 47. Americas Biological Safety and Biocompatibility Testing Revenue Market Share by Country (2021-2026) Figure 48. Americas Biological Safety and Biocompatibility Testing Sales Market Share by Type (2021-2026) Figure 49. Americas Biological Safety and Biocompatibility Testing Sales Market Share by Application (2021-2026) Figure 50. United States Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 51. Canada Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 52. Mexico Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 53. Brazil Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 54. APAC Biological Safety and Biocompatibility Testing Sales Market Share by Region in 2026 Figure 55. APAC Biological Safety and Biocompatibility Testing Revenue Market Share by Region (2021-2026) Figure 56. APAC Biological Safety and Biocompatibility Testing Sales Market Share by Type (2021-2026) Figure 57. APAC Biological Safety and Biocompatibility Testing Sales Market Share by Application (2021-2026) Figure 58. China Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 59. Japan Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 60. South Korea Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 61. Southeast Asia Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 62. India Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 63. Australia Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 64. China Taiwan Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 65. Europe Biological Safety and Biocompatibility Testing Sales Market Share by Country in 2026 Figure 66. Europe Biological Safety and Biocompatibility Testing Revenue Market Share by Country (2021-2026) Figure 67. Europe Biological Safety and Biocompatibility Testing Sales Market Share by Type (2021-2026) Figure 68. Europe Biological Safety and Biocompatibility Testing Sales Market Share by Application (2021-2026) Figure 69. Germany Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 70. France Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 71. UK Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 72. Italy Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 73. Russia Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 74. Middle East & Africa Biological Safety and Biocompatibility Testing Sales Market Share by Country (2021-2026) Figure 75. Middle East & Africa Biological Safety and Biocompatibility Testing Sales Market Share by Type (2021-2026) Figure 76. Middle East & Africa Biological Safety and Biocompatibility Testing Sales Market Share by Application (2021-2026) Figure 77. Egypt Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 78. South Africa Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 79. Israel Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 80. Turkey Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 81. GCC Countries Biological Safety and Biocompatibility Testing Revenue Growth 2021-2026 ($ millions) Figure 82. Manufacturing Cost Structure Analysis of Biological Safety and Biocompatibility Testing in 2026 Figure 83. Manufacturing Process Analysis of Biological Safety and Biocompatibility Testing Figure 84. Industry Chain Structure of Biological Safety and Biocompatibility Testing Figure 85. Channels of Distribution Figure 86. Global Biological Safety and Biocompatibility Testing Sales Market Forecast by Region (2027-2032) Figure 87. Global Biological Safety and Biocompatibility Testing Revenue Market Share Forecast by Region (2027-2032) Figure 88. Global Biological Safety and Biocompatibility Testing Sales Market Share Forecast by Type (2027-2032) Figure 89. Global Biological Safety and Biocompatibility Testing Revenue Market Share Forecast by Type (2027-2032) Figure 90. Global Biological Safety and Biocompatibility Testing Sales Market Share Forecast by Application (2027-2032) Figure 91. Global Biological Safety and Biocompatibility Testing Revenue Market Share Forecast by Application (2027-2032)
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療機器）の最新刊レポート
LP Information社の 医療機器・消耗品分野 での最新刊レポート
よくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
